Skip to search formSkip to main contentSkip to account menu

FR 144420

Known as: FR-144420, FR144420 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Nicotinic AcidsNitro Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
In vitro effects of new generation fungal derived nitric oxide donors on rabbit basilar artery.
The fungal derived nitric oxide donors, (E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK409) and N-[(E)-4-ethyl-3-[(Z… 
1997
1997
Structure-Activity Relationships of Spontaneous Nitric Oxide Releasers , FK 409 and its Derivatives
(6)-(E)-4-Ethyl-2-[(E)-hydroxyimino] 5 nitro-3-hexenamide (FK409) shows both potent in vitro vasorelaxant and antiplatelet… 
1996
1996
Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners.
We examined whether p.o. biological activities of (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (FK409), a… 
1996
1996
Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)